Literature DB >> 18810307

Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives.

P Zwanzger1, J Diemer, B Jabs.   

Abstract

Anxiety disorders are among the most frequent psychiatric disorders. Experimental evidence supports both psychotherapy as well as pharmacotherapy as effective treatments. There is, however, a controversy concerning the efficacy of a combination of both approaches. While some studies suggest that combined treatment enhances efficacy, others report conflicting results. This article traces the positions in this debate. We present the results from two recent meta-analyses and discuss implications for clinical practice and further research. We suggest that a research strategy that strives to establish differential indications based on patient characteristics should be preferred over attempts to reach a global judgement of the question, which appears too simplistic given the complexity of the issue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810307     DOI: 10.1007/s00702-008-0116-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  27 in total

Review 1.  Current status of psychotherapeutic interventions for social phobia.

Authors:  R G Heimberg
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

2.  Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala.

Authors:  W A Falls; M J Miserendino; M Davis
Journal:  J Neurosci       Date:  1992-03       Impact factor: 6.167

Review 3.  Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.

Authors:  T A Furukawa; N Watanabe; R Churchill
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats.

Authors:  A Sophie Parnas; Marianne Weber; Rick Richardson
Journal:  Neurobiol Learn Mem       Date:  2005-05       Impact factor: 2.877

5.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Authors:  D H Barlow; J M Gorman; M K Shear; S W Woods
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

6.  An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.

Authors:  Rosario B Hidalgo; Larry A Tupler; Jonathan R T Davidson
Journal:  J Psychopharmacol       Date:  2007-11       Impact factor: 4.153

Review 7.  An integrated approach to treatment of obsessive compulsive disorder.

Authors:  J H Greist
Journal:  J Clin Psychiatry       Date:  1992-04       Impact factor: 4.384

8.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Authors:  J C Ballenger; G D Burrows; R L DuPont; I M Lesser; R Noyes; J C Pecknold; A Rifkin; R P Swinson
Journal:  Arch Gen Psychiatry       Date:  1988-05

9.  Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Authors:  Stefan G Hofmann; Alicia E Meuret; Jasper A J Smits; Naomi M Simon; Mark H Pollack; Katherine Eisenmenger; Michael Shiekh; Michael W Otto
Journal:  Arch Gen Psychiatry       Date:  2006-03

10.  Pharmacological treatment of social anxiety disorder: a meta-analysis.

Authors:  Carlos Blanco; Franklin R Schneier; Andrew Schmidt; Carmen-Rosa Blanco-Jerez; Randall D Marshall; Arturo Sánchez-Lacay; Michael R Liebowitz
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

View more
  2 in total

1.  Mind over PMDD: A Glimpse into the Process of Pharmacotherapy-Psychotherapy Combination Treatment.

Authors:  Gili W Adler Nevo; Colman Nefsky
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-05

Review 2.  Pharmacological treatment of anxiety disorders: current treatments and future directions.

Authors:  Frank J Farach; Larry D Pruitt; Janie J Jun; Alissa B Jerud; Lori A Zoellner; Peter P Roy-Byrne
Journal:  J Anxiety Disord       Date:  2012-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.